LACMED (5341.KL) has a MoatMap StockRank of 41/100 based on Quality (57/100), Value (52/100), and Momentum (19/100) factor scores. The current signal is HOLD. A small-cap healthcare player with weak financial metrics and no observable competitive advantage. It does not align with our high-conviction CDMO or advanced packaging themes.
LACMED manufactures and distributes medical consumables, surgical instruments, and hospital equipment. The company benefits from stringent medical device registrations and long-term supply contracts with public and private hospital networks. It is a defensive healthcare player capitalizing on rising healthcare expenditure and hospital capacity expansions in Southeast Asia.
| Price | $0.17 |
| Market Cap | $79M |
| P/E (TTM) | 3.71 |
| P/E (Forward) | 10.07 |
| Price/Book | 2.35 |
| Return on Equity | 20.7% |
| Return on Invested Capital | 26.3% |
| Debt/Equity | 25.54 |
| Gross Margin | 28.2% |
| Operating Margin | 4.3% |
| Revenue Growth | -38.1% |
| Dividend Yield | 0.9% |
| Free Cash Flow | $-2M |
LACMED operates in the Medical Devices industry, part of the Healthcare sector (Malaysia).